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Abstract
In order to learn more about the small subset of CD4CD8- TCRa/S/CD3 + peripheral T
lymphocytes, we firstly characterized at the cellular and molecular levels the CD4-CD8- LD1 cell
line isolated from the spleen of an MRL/lpr-lpr mouse. Secondly we studied its functional
properties. LD1 cells are Thy1 + CD5+ CD4-CD8- LFA-1 + PgP-1+ and do not bind the T cell
precursor-specific antibodies Joro 37-5 or Joro 75. They are negative for IgM, B-220, BP-1, J11d,
Lyb8, la, F4/80, BP-2, and Mac-1 surface markers. LD1 cells have deleted the TCR5 locus, have
rearrangements at the TCR7 gene cluster (i.e. a V71 -JT1 -C71 and a V.4.3-JT4-CT4) and have
two rearrangements of the TCR/3 gene cluster (I.e. a D^ 1 -J 0 1 and V - D - J S 2 ) . LD1 cells produce
normal sized RNA transcripts from TCRa and /3 genes and lower levels of 7-mRNA. These cells
bind CD3- and pan-TCR/3-specific antibodies as determined by FM analysis. We conclude that LD1
cells bear a TCRa/S/CD3 type of receptor complex. LD1 cells fail both In vivo and In vitro to
differentiate Into CD4+ or CD8+ cells. These cells help B lymphocytes to mature Into antibody-
secreting cells, secrete IL-3 and IL-6 but not IL-2, IL-4, or IL-5, and exert no detectable cytolytlc
activity. These results together with recent reports of antigen-specific CD4CD8" TCRa/3/CD3+
cytotoxic T cell lines show that the CD4CD8" TCRa/3/CD3+ subset comprises functionally
competent helper and cytotoxic T lymphocytes and thereby argue for their potential to participate
in immune responses. Our results also suggest that cells like LD1 represent terminally
differentiated T lymphocytes rather than cells with precursor potential for CD4+ or CD8+
TCRa(3/CD3+ T lymphocytes.
Introduction
A CD4-CD8- CD3+ subset of thymocytes was first identified
in man (1). Subsequently, the existence of CD4-CD8-
TCRa/3/CD3+ thymocytes in normal mice was documented
(2-4). These mouse thymocytes were found to appear late in
ontogeny (3), the time when CD4-CD8- TCRa/3/CD3+ cells
appear in the human thymus has not been defined. In vitro,
CD4-CD8- TCRa/3/CD3+ cells can develop from CD4-CD8-
TCR/CD3- PRO-T lymphocyte clones without passing through
a CD4+CD8+ stage (5). Recently it was shown that at least
some CD4-CD8- TCRa/3/CD3+ cells may leave the thymus
and migrate to peripheral lymphoid organs (6). In spite of all this
knowledge, there are still several critical aspects of this subset
of T cells that remain undefined. Thus, we still lack information
on (i) the functional properties of these cells; (ii) whether or not
they can develop into CD4+ or CD8+ T cells; (iii) whether or not
they are subjected to thymic positive and negative selection
processes in a similar fashion to CD4+CD8- and CD4-CD8 +
TCRaj3/CD3+ lymphocytes; (iv) whether they recognize antigen
in an MHC-restricted manner like the other two major
TCRa0/CD3+ T cell populations do; and (v) whether they can
also develop extrathymically.
Mice carrying the Lpr or the Gld mutations develop a
lymphoproliferative disorder due predominantly to a massive
accumulation of CD4-CD8- TCRa/3/CD3+ lymphocytes (7,8).
It is unclear, however, whether the accumulation of these cells
in lymphoid organs of these mutant mice is due to an over-
production and consequent progressive accumulation in
lymphoid tissues, to an increased life span of peripheral
CD4-CD8- TCRa/3/CD3+ cells, or to both. Patients suffering
from systemic lupus erythematosus (SLE) were recently reported
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to have increased numbers of CD4-CD8- TCRa/3/CD3 +
lymphocytes (9). These observations in man and in mice suggest
that CD4-CD8- TCRa0/CD3+ lymphocytes could be involved
in the physiopathogeny of some autoimmune diseases and
lymphoproliferative disorders.
Several years ago we described the establishment in culture
of the LD1 CD4-CD8- Thy1 + cell line which was obtained from
the spleen of an MRL/Lpr-Lpr mouse (10). We have now
characterized further these cells and found that they carry on
the cell membrane a TCRa/3/CD3 type of receptor complex. We
then used this CD4-CD8- TCRa|S/CD3 + cell line both
to test whether CD4-CD8- TCRa/3/CD3 + lymphocytes can
generate CD4 + or CD8+ T cells and to gain insight on the
functional properties of this T cell subset
Methods
Mice
C57BL/6 Nu/Nu mice (5- to 7-week-old females) were from
Bomholgard (Denmark). AKR/J mice (8- to 12-week-dd male and
female) were from our animal facilities
Cell preparations
Spleen and thymus cell suspensions were prepared free of
erythrocytes as described (5,10). Cells were washed and
resuspended in culture medium [Iscove's modified Dulbecco
medium + FCS (5%) + 2-mercaptoethanol (2ME; 5 x 10~5 M)
+ L-glutamine (2 mM) + gentamycin (50 nQlrrX)] at the desired
concentrations.
Cell lines
The LD1 cell line was obtained from the spleen of an
MRL/Lpr-Lpr mouse and established in culture using culture
medium supplemented with WEHI-3 supernatants (10). These
cells were subsequently found to grow in culture medium without
exogenous growth factors (10). LD1 cells are not malignant cells
in that they do not form tumors in Nu/Nu mice during 12-16
weeks of observation (R.P., unpublished observations). LD1 cells
expressing the highest levels of CD3 were isolated by cell sorter
using a FACS 440 instrument as described (11). They were
subsequently expanded and were used in all experiments
described here. LD1 cells are propagated in tissue culture flasks
by changing them in fresh culture medium ( -2 x 10s cells/ml)
every 2 - 3 days.
The 2.19 CD4+CD8- TCRa/3/CD3+ T helper line (12), the
marrow PRO-T clone C4-77/3 (13), the fetal thymocyte clone
FTH5 (14), the IL5-responsive B13 cell line (15), the IL6-sensitive
hybridoma B45 (provided to us by A. Rolink, Basel Institute for
Immunology, Basel), and the ET thymic epithelial clone (5), were
also used.
Monoclonal antibodies
mAbs against the following surface antigens were used: B-220
(hybridoma 14.8), Lyb8 (hybridoma Cy 341.2), BP-1, J11d, PgP-1
(hybridoma I42/5), BP-2, F4/80, Mac-1 (hybridoma M1/70),
la (hybridoma M5/114), IL5R (hybridoma R52.120), IL2R
(hybridoma 7D4), IL3R (hybridoma CC11), CD4 (hybridoma
gk1.5), CD3 (hybridoma 500A2), pan TCR /3 chain (hybridoma
H57-597), LFA-1 (hybridoma FD441-8), and T cell precursors
(hybridomas Joro 37-5, Joro 75). The reports describing the
development and characterization of all of these mAbs are listed
elsewhere (5,11,13-15,17). Fluorescein isothiocyanate (FITC)-
and biotin-conjugated anti-Thyl .2 or LyT2 (CD8) and PE-L3T4
(CD4) were from Becton Dickinson Phycoerythrin (PE)- or
FITC-labeled goat anti-hamster IgG, FITC anti-mouse Ig,
FITC ant-rat IgG, and PE - streptavidin were from Southern
Biotechnology Associates. FITC-conjugated anti-rat lgG1, lgG2a,
lgG2b, and IgM were from Binding Site Ltd and FITC-
streptavidin was from Amersham.
Immunofluorescence staining and flow fluorometry (FM) analysis
Single and two color stainings were performed as detailed
elsewhere (5) and FM analysis was carried out with a FACScan
instrument (Becton Dickinson). The data collected from 1 -
2 x 104 cells were analyzed with Consort 30 software (5).
Functional assays
Differentiation of LD1 cells. LD1 cells suspended in PBS were
injected (106 cells/10 ^I/lobe) into the thymus of sublethally
irradiated (600 rads of >-rays) H-2-compatible Thy1 congenic
AKR/J mice as described (16,17) Two and 4 weeks later, the
thymuses were obtained, cell suspensions were prepared, and
the presence of Thy1.2+ CD4+ or Thy1-2+ CD8+ donor-
derived cells was determined by two-color FM analysis.
In another set of experiments, LD1 cells (105 cells/well) were
cultured with monolayers of the ET thymic epithelial clone in
six-well Costar plates as detailed elsewhere (5). As a positive
control, FTH5 PRO-T lymphocytes (14) were co-cultured with ET
thymic epithelial cells (5). Ten days later, the lymphoid cells were
harvested and the presence of CD4+, CD8+, and CD3+ cells
was determined by two-color FM analysis. LD1 cells (0.5 x 108
cells/ml of culture medium) were exposed to several doses of
5-azacytidine (Sigma Chemicals Co., final concentrations 1,10,
20, 40, and 50 ^g/ml) at 37°C for 3 - 5 days in cultures grown
in tissue culture flasks (AS Nunc, Denmark). The cells were
harvested, washed, and assayed for expression of surface CD4
or CD8 by single-color FM analysis.
In all experiments, thymocytes from normal AKR mice were
used as positive controls in FM analysis.
Production of cytokines. LD1 cells (106 cells/ml) were cultured
in medium alone or in culture medium containing phorbol
myristate acetate (PMA, 10 ng/ml) and ionomycin (500 ng/ml) at
37°C for 48 h. The supernatants were collected, filtered (0.2 /xm
Acrodisc filters) and assayed for cytokine activity. The presence
of interleukin 2 (IL-2), IL-3, IL-4, IL-5, or IL-6 activity in the
supernatants was determined as detailed elsewhere (15,18) using
the following target cells: FTH5 (IL-2 and IL-4), C4-77/3 (IL-3),
B13 (IL-5), and B45 (IL-6). As positive controls in these assays,
we used recombinant interleukins (19) at a concentration of
20 U/ml. Because B13 cells used to detect IL-5 also proliferate
in IL-3 (15), the presence of IL-5 in the supernatants tested was
assessed by performing the assays in the presence or absence
of the IL-5R-specific mAb R52.120 (15) (final concentration
25 /tg/ml). The presence of IL-3 activity in the supernatants was
determined by using C4-77/3 cells, which respond to IL-3 but
not to IL-5, and B13 cells, which respond to both IL-5 and IL-3.
FTH5 cells proliferate in either IL-2 or IL-4, but not IL-3, IL-5,
or IL-6. Therefore, they were used to detect IL-2/IL-4 activities.
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Fig. 1. Phenotype of LD1 cells was determined by single-color FM analysis.
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Cell proliferation was measured by [3H]thymidine uptake
(1 ftCi/well, TRA 185 MBq, Amersham) during the last 6 h of a
2 day culture period. The results are given as units/ml of biological
activity, where 1 unit is defined as the dilution giving half of the
maximum prohferative response.
Helper and cytotoxic T ceil functions. The capacity of LD1 cells
to assist B lymphocytes from spleen of C57BL/6 Nu/Nu mice
to mature into antibody-secreting cells was studied in a
Concanavalin A (Con A)-facilitated microculture assay as detailed
before (10). The FTH5 PRO-T clone and lipopolysacharides (LPS)
(50 /ig/ml) were included in this assay as negative and positive
controls, respectively. The number of antibody (IgM)-secreting
cells was determined by the reverse hemdytic plaque assay (20)
after 5 days of culture at 37°C. The results are expressed as PFC
per culture and are the mean of triplicate cultures.
The capacity of LD1 cells or the cytotoxic 4E7 T cells (21)
(positive control) to exert cytotoxic activity was tested in a
PHA-facihtated microcytotoxicity assay using as target cells
51Cr-labeled LPS-stimulated spleen cells or EL-4 T lymphoma
cells and were performed for us by H. G. Rammensee as
described (21).
Isolation and analysis of nucleic acids. DNA and RNA
preparation, restriction enzyme digestions, agarose gel electro-
phoresis, DNA and RNA blotting procedures, probe preparations,
hybridization procedures, and autoradiography were performed
as described previously (14,22,23).
DNA probes. The following probes used were isolated inserts
which were ^P-labeled using a random primed DNA labeling
kit (Boehringer Mannheim, Mannheim). The 5' D,1 genomic
probe (600 bp H/ndlll-H/ndlll fragment), the 5' Da2 genomic
probe (850 bp H/ndlll-EcoRI fragment) (23), the JT1 probe
(1.2 kb/4val-H/ndlll genomic fragment), the c72 probe (1.0 kb
EcoRI-H/ndlll genomic fragment) (24), the c71 cDNA probe
(900 bp Ava\ -EcoRI fragment) (25), the 5' Dfl1 probe (1.2 kb
Pst\-Acc\ genomic fragment), the Jfl1 probe (2.0 kb Pst\-
EcoRI genomic fragment), the J41 probe (400 bp Pvu\\-Sau3A
genomic fragment), the J<,2 probe (800 bp C/al - EcoRI
genomic fragment) (26,27), the 4.1 cDNA probe specific for the
constant region of the TCR fi gene complex (28), and the Co
probe (300 bp Nco\ —/Avail fragment from the constant region
of the a chain cDNA clone T1.2) were used.
Results and discussion
Phenotype
The LD1 cell line was phenotypically characterized by
immunofluorescence staining and FM analysis using a pane)
of mAbs reactive with surface molecules expressed by T
lymphocytes, B lymphocytes, or myeloid cells (Fig. 1). Among
the T cell lineage surface markers tested, LD1 cells were positive
for Thy1 and CD5 (Ly1) but negative for CD4, CD8, and the T
cell precursor specific markers Joro 37-5 and Joro 75. LD1 cells
expressed neither IgM, la, B-220, J11d, BP-1, Lyb8 B cell lineage
markers nor F4/80, Mac-1, BP-2 myeloid-cell lineage antigens.
They carry LFA-1 and PgP-1 adhesion molecules on the cell
membrane but no detectable IL-3R, IL-5R, or the p55 chain of
the IL-2R complex.
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Fig. 2. (A) Southern blot analysis of the TCR5 loci in LD1 cells and MRUlpr - Ipr liver (B) Analysis of the TCR? gene cluster in LD1 cells was earned
out by Southern blot analysis. The nomenclature and assignment of germline and rearranged TCR7 gene bands is according to (24).
LD1 cells express a TCF)a/S/CD3 receptor complex
In order to further characterize the LD1 cell line, we studied by
Southern blot analysis the state of the TCR6, 7, and 0 genes
in these cells. The analysis of H/ndlll- or EcoRI-digested DNAs
from these cells and hybridization with J41-, 5' D{1-, and 5'
Dj2-specific probes indicated that LD1 cells have deleted the
TCR6 locus (Fig. 2A).
LD1 cells had a V 71-J 71-C 71 and a V74.3-J74-C74,
rearrangements in the TCR7 gene cluster (detected by using
H/ndlll-digested DNA and the J71 probe) and the ?3 pseudo-
gene in the germline configuration (Fig. 2B). No rearrangement
of the 72 gene was detected using EcoRI-digested DNAs and
the C72 probe [nomenclature of TCR7 genes is according to
Traunecker ef a/. (26)]. The state of the TCR/3 gene was assessed
using H/ndlll- or EcoRI-digested DNAs and probes specific for
the Jp1, Jg2, 5' Dpi, and 5' 0^2 chromosomal regions. Figure
3 shows only the results obtained with the /-//ndlll-digested DNA
as the information obtained using EcoRI-digested DNA was the
same. LD1 cells had a Dff1 - JS1 rearrangement (detected with
the Jfl1 and 5' D 1^ probes), with J ^ and its surroundings in the
germline in one chromosome. In the other chromosome there
was a deletion of the entire J01 -CP1 region and a V - D - J ^
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rearrangement (detected with the Jfl2 probe). With H/ndlll-
digested DNA, the 5' 0^2 probe only detected the joining of D
to Jp2 and the germline J ^ band in the other allele because
there is a H/ndlll site in the middle of the region comprised by
this probe (see Fig. 3 bottom).
Next we assessed by Northern blot analysis the presence of
RNA transcripts from the TCRa, p\ and 7 genes in LD1 cells.
As a positive control, RNA from the 2.19 cells, a CD4+CD8-
TCRa/3/CD3+ T helper line (11), was included in these analyses.
Figure 4 shows that LD1 cells produce normal sized RNA
transcripts from the TCRa and /3 genes and lower levels of
7-mRNA.
We also studied by FM analysis the expression of TCRa/3/CD3
receptor complex on the cell membrane of LD1 cells using the
CD3e-specific antibody 500A2 (29) and the pan-TCR /S chain-
specific antibody H57-597 (30). Figure 5 shows that LD1 cells
bound both the CD3- and the pan-TCR |3 chain-specific
antibodies. Antibodies against Vp8 or V317a gene products did
not bind to LD1 cells. Taken together, we conclude that LD1 cells
express a TCRaj9/CD3 type of receptor complex.
Functional potential
LD1 cells do not give rise to CD4+ or CD8+ cells. The finding
that LD1 cells belong to the CD4-CD8- TCRa/3/CD3+ subset
of T cells allowed us to test whether these cells can differentiate
further into CD4+ or CD8+ cells. This was assessed in vivo by
injecting LD1 cells into the thymus of sublethally irradiated (600
rad) H-2-compatible Thy1 congenic mice (AKR/J, H-^, Thy1.1)
and assaying the thymuses 2 - 4 weeks later for the presence
of Thy1 2+ CD4+ and Thy1.2+ CD8+ cells by two-color FM
analysis. In all six mice tested, while Thy1.2+ cells were
detected (range 35.1 -56%) none of these cells co-expressed
CD8 or CD4 surface markers (Table 1).
In vitro studies in which LD1 cells were cocultured with the
thymic epithelial cells ET [able to induce differentiation of
CD4-CD8- PRO-T lymphocyte clones into CD4 + CD8-
TCR/CD3+ cells (5)] showed that while FTH5 PRO-T cells
generated CD4+CD8- cells, LD1 cells did not (Fig. 6). 5-Aza-
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Fig. 3. The state of the TCR/3 gene cluster in LD1 cells was assessed
by Southern blot analysis using H/ndlll-digested DNA. Similar information
was obtained using EcoRI-digested DNA.
1.7 M 1.3 1.5
TCRa TCR(3 TCR-
Fig. 4. The expression of RNA transcripts from TCRa, p, and 7 genes
mLD1 cells and 2.19 T cells (positive controQ was detennined by Northern
blot analysis using the constant region-specific probes Co, 4 1 cDNA0,
Cand T1 DNA
560 A CD4- CD8~ TCRa/3/CD3+ helper T cell line
Control CD3(500A2)
1
c •
ell
o
s
dJAV \ i
lee ' ' >ee ' ' '
TCRap(H57-597)
^MJ^
Log 10 fluorescence intensity
Fig. 5. The expression of CD3 and a/3 heterodimers on the cell membrane of LD1 cells was determined by FM analysis with the CD3 e chain-
specific 500 A2 mAb and the pan-TCR /3 chain-specrfic H57-597 mAb, using as the second-step reagent FITC anti-hamster IgG antibody Control
- LD1 cells stained with second-step antibody only.
Thymus
Q
O
LD1
FTH5
Q
O
CD8
CD8
a -.
a :
Q "-1
o
a -^
1
• W<
1
8
10" i n '
•
CD3
-I
] \
1
I
CD3
a :
a i
8 V
i
CD8 CD3
Fig. 6. LD1 cells or FTH5 PROT lymphocytes were cultured with the ET thymic epithelial cells for 10 days (5). The presence of CD4 + , CD8 +
and CD3+ cells was determined by two-color FM analysis. ET thymic epithelial cells induce PROT cells to generate CD4+CD8- TCRa|3/CD3 +
CD4-CD8- TCRa/3/CD3 + , and T C R T « / C D 3 + cells but not CD8-bearing cells (5)
Table 1. LD1 cells do not give rise in vivo to CD4+ or
cells
Mouse8 % positive cells (FM analysis)
Thy1 2 + Thy1 2+ CD4 Thy1 2+ CD8 +
1
2
3
4
5
6
35
42
56
38
40
39
aLD1 cells were injected into the thymus of stiblethally irradiated,
H-2-compatible Thy1 congenic AKR/J mice. Two to 4 weeks later, the
presence of Thy 1.2+ CD4+ andThy1.2+ CD8+ LD1-denved cells was
determined by two-color FM analysis (see Methods for details).
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Fig. 7. The capacity of LD1 cells to assist B lymphocytes from the spleen
of Nu/Nu mice was determined in a Con A-facilitated microculture assay
(10). FTH5 PRO-T cells known to lack helper function (14) were used
as negative control The number of IgM PFC per culture was determined
by the reverse hemolytic Protein A plaque assay.
cytjdine, a drug able to induce expression of CD4 or CD8 (13,31),
also failed to induce LD1 cells to express CD4 or CD8 at the
several concentrations tested (1-50 g/ml).
The simplest interpretation of these results is that LD1 cells are
CD4-CD8- TCRaj3/CD3+ terminally differentiated lymphocytes
rather than cells with precursor potential for CD4+ or CD8 +
TCRo/3/CD3+ cells.
Cytokine production. The potential of LD1 cells to produce IL-2,
IL-3, IL-4, IL-5, and IL-6 was studied by testing supernatants from
either (PMA + ionomycin)-stimulated or unstimulated LD1 cells
for their growth promoting effect on the respective target cells
for the different interieukins studied (see Methods for details).
Unstimulated LD1 cells produced little IL-3 and IL-6 activities but
no detectable IL-2, IL-4, or IL-5 (Table 2). LD1 cells stimulated
by PMA + ionomycin secreted higher levels of IL-3 and IL-6 but
no detectable IL-2, IL-4, or IL-5 (Table 2). Previously, it was shown
by RNA-RNA in situ hybridization that LD1 cells do not
synthesize mRNA for IL-4 (14), in agreement with the results
obtained here. Thus, LD1 cells can secrete IL-3 and IL-6, but
they seem unable to synthesize IL-2, IL-4, and IL-5. It is unclear,
at present, whether this pattern of cytokines produced by LD1
cells is a feature of cells generated in Lpr mice, a property of
double negative peripheral T cells, or a peculiarity of LD1 cells.
Helper function for B lymphocytes. The capacity of LD1 cells to
assist B lymphocytes from the spleen of Nu/Nu mice to mature
into antibody-secreting cells was studied in a Con A-facilitated
assay which detects helper activity for B cells regardless of the
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Table 2. Secretion of cytokines by LD1 cells (in units/ml)
LD1 cells treated with
None
PMA + ionomycin
IL-2
<1
<1
IL-3
17
210
IL-4
<1
<1
IL-5
<1
<1
IL-6
12
234
Supernatants from LD1 cells cultured in the presence or absence of
PMA + ionomycin at 37°C for 48 h were assayed for the interieukins
indicated above as detailed in Methods.
specificity of the T cell line studied (10). Negative controls in these
experiments were spleen B cells from Nu/Nu mice cultured with
either Con A alone or Con A plus the fetal thymocyte clone FTH5
known to lack helper activity (14). Figure 5 shows that LD1 cells
efficiently help B lymphocytes to mature into antibody-secreting
cells, confirming our previous results obtained with resting B
lymphocytes from normal mice (10). We have determined that
B cells stimulated by LD1 cells secrete IgM as well as IgG
subclasses [lgG1, lgG2a, lgG2b, and lgG3 (10)] LD1 cells tested
negative for mycoplasma contamination several times, ruling out
the possibility that the helper function for B lymphocytes was due
to products of mycoplasma. The helper activity on B lymphocytes
of LD1 cells was also documented by other investigators (C.
Martinez-A. and A. Coutinho, personal communication). Super-
natants from LD1 cells support maturation of B lymphocytes into
IgM-secreting cells, suggesting that the helper function for B cells
of LD1 cells is, at least partially, due to soluble factors. The soluble
factor(s) responsible for the helper activity on B cells remains to
be identified, but it must be different from IL-2, IL-4, and IL-5
(Table 2). IL-6 and neuroleukin are potential candidates and
experiments to test them are under way.
Cytotoxic function. The cytotoxic potential of LD1 cells was
assessed in a PHA-facilitated 51Cr-release cytotoxic assay which
detects cytotoxic activity regardless of the specificity of the effector
cells. While the CD4-CD8+ cytotoxic 4E7 T cells killed the
target cells, LD1 cells did not exhibit this function at the different
effector to target cell concentrations tested (data not shown).
Concluding remarks
Our results indicate that LD1 cells are CD4-CD8- TCRa(3/
CD3+ peripheral T lymphocytes with helper function for B
lymphocytes. We failed to obtain in vivo or in vitro any evidence
that LD1 cells have precursor potential to develop into CD4+ or
CD8+ lymphocytes. Thus, we favor the view that cells like LD1
represent a separate subpopulation of terminally differentiated
mature T lymphocytes.
Although more work is clearly needed to understand the
biological meaning for the existence of CD4-CD8- TCRa0/
CD3+ lymphocytes, the finding that cells like LD1 can provide
helper function for B lymphocytes (9,10, this study), and the
recent reports describing antigen-specific CD4-CD8- TCRa0/
CD3+ cytolytic T cell lines (32,33) argue that at least some
CD4-CD8- TCRaj3/CD3+ cells are functionally competent and,
thereby, with potential to actively participate in immune
responses. A recent study reported increased numbers of
CD4-CD8- TCRa/3/CD3+ lymphocytes in patients suffering
from SLE, a multisystemic autoimmune disease (9). In order to
be able to understand how and if CD4-CD8- TCRa/3/CD3+
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lymphocytes participate in the physiopathogeny of autoimmune
diseases we must first determine whether or not these cells are
subjected to positive and negative selection in the thymus in a
similar fashion to CD4+ and CD8+ TCRa/3/CD3+ thymocytes
(34), whether or not CD4-CD8- TCRa/3/CD3 + cells can also
develop extrathymically, and if the requirements for antigen-
specific activation of these cells are similar to or different
from those for the other two major subsets of TCRa/3/CD3 +
lymphocytes.
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